Professional Documents
Culture Documents
Financials: Banks Well Equipped For A Time Like This
Financials: Banks Well Equipped For A Time Like This
Financials
Banks well equipped for a time like this
INDIA | FINANCIALS | SECTOR UPDATE 2 December 2020
HDFCB
The bank will gain more market share based on the following – it has a complete suite
of products for diverse customer needs, it leverages technology that offers an omni-
channel experience, it has renewed its thrust on the semi-urban and urban market.
Strong underwriting and strict monitoring of loans will enable it to contain its stressed Manish Agarwalla, Research Analyst
Sujal Kumar, Research Analyst
portfolio at manageable levels; we factor 2% slippage and 1% standard restructured
loan in FY21.
Maintain BUY with a revised target of Rs 1,750 vs. Rs 1,380 earlier.
ICICIBC
Main points that give us confidence on the bank’s ability to manage the current
asset-quality crisis without a material impact on its return ratios –collection efficiency
returned to 97% of pre-covid levels; it has guided for normalised credit cost in FY22.
We factor an eventual mortality of c.3% and standard restructuring of c.2% in FY21.
Covid-related buffer (Rs 88bn; 1.2% of gross customer asset) would enable it to meet
post-moratorium credit shocks.
Maintain BUY with a revised target of Rs 560 vs. Rs 520 earlier.
IIB
Valuation improved to 1.5x (one-year forward P/ABVPS) from distressed level of 0.4x
in March 2020.
What allayed investor concerns? The development in the last six months –
depositors’ trust in the bank was restored, ability to raise capital to protect its
balance sheet demonstrated, better-than-expected recovery in the business activity
(collections etc.). Therefore, valuation is no longer at distressed levels.
Return to a normalized growth trajectory and credit cost would be a key driver for
further re-ratings. The aftermath of the moratorium will start hitting banks. Here, we
see challenge in terms of growth and see a long wait before credit-cost normalizes.
We model 3.3% slippage and 4% standard restructuring in FY21.
Based on return on risk weighted asset, some of the front-line private banks (Axis,
ICICI) are better placed both in terms of valuation and return ratio matrices.
Downgrade to NEUTRAL from BUY with a revised target of Rs 925 vs. Rs 720 earlier.
KMB
Strong capital (tier-1 at 22.8%), higher covid provisions (Rs 12.7bn or 0.62% of loan)
and excellent deposit franchise (57.1% CASA at 3.87% cost of SA) should help KMB to
grab opportunities in a post-covid world.
It is ready to focus on asset-side growth.
A strong balance sheet should help it to gain market share.
Higher margins and cost optimization should lead to enhanced return ratios over the
medium term.
Maintain Buy with a revised target of Rs 2,150 vs. Rs 1,600 earlier.
SBI
We are sanguine about the asset quality outcome given that fact that 1. Retail loan
are largely to salaried and PSU entity 2. The corporate credit cycle between FY16-18
recognized bulk of weak and marginal cases in corporate book 3. Agriculture as a
segment has done well in India owing to better rain and harvest 4. The Government’s
ECLGS has aided stress MSME segment.
We factor total stress book of 3.5% for FY21.
Strong NII performance and manageable credit cost warrants a Buy given the
subdued valuation.
Maintain Buy with a revised TP of Rs310 (from Rs 285).
DCBB
The MSME segment hurt by the extended lockdown and declining economic activity.
Though the bank’s MSME/LAP portfolios are backed by hard collaterals, and resultant
loss-given-default may not be high, we are cautious about delayed repayments and
resultant higher credit costs for the bank in the near term.
Maintain Neutral with a revised target of Rs 125 vs. Rs 80 earlier.
% of total loan
Corporate loan 37 10 33 30 31 37 50
MSME loan* 11 11 16 9 8 8 11
Agri loan 6 21 11 9 12 13 8
Retail loan 47 58 41 52 49 42 31
Loan mix
Mortgage (HL, LAP) 24 42 6 32 6.7 23 18
Unsecured (PL, CC, CD) 10 16 9 4.5 6 6.2
Vehicle loan 7 8 11 9 27 8 3
Micro finance 11
Other retail loan 7 8 7 2 0 5 4
Capital Position CET1, % 15.4 14.2 17.0 16.5 14.8 22.6 10.5
Liquidity position Liquidity coverage ratio, % 118 142 153 145 140 182 159
Source: RBI, PhillipCapital India Research
6
7
8
9
10
11
12
13
-
1,000
2,000
3,000
4,000
5,000
6,000
7,000
Sep-14 Mar-13
Jun-13
Jan-15 Dec-15 Sep-13
Dec-13
May-15 Mar-16 Mar-14
Sep-15 Jun-16 Jun-14
Sep-14
Jan-16 Sep-16 Dec-14
Dec-16 Mar-15
May-16 Jun-15
Sector Trends
CP Outstanding
May-17
May-18 Sep-18
Mar-18
CD Outstanding
Sep-19 Dec-19
Dec-19
Jan-20 Mar-20
Sep-20 Sep-20
64
66
68
70
72
74
76
78
80
8
9
10
11
12
13
14
-5
-10
0
5
10
15
20
25
30
35
0
20
40
60
80
100
120
140
160
Sep-12 Mar-12
Jan-13 Mar-13 Jun-12
May-13 Jun-13 Sep-12
Sep-13 Dec-12
Sep-13 Dec-13 Mar-13
Jan-14 Mar-14 Jun-13
May-14 Jun-14 Sep-13
Sep-14 Dec-13
Agriculture
Jun-15 Sep-14
May-15 Dec-14
Sep-15 Mar-15
Sep-15 Dec-15 Jun-15
Jan-16 Mar-16 Sep-15
May-16 Jun-16 Dec-15
Jun-16
Jan-17 Mar-17 Sep-16
Jun-17 Dec-16
FINANCIALS SECTOR UPDATE
May-17 Mar-17
Sep-17
Sep-17 Dec-17 Jun-17
Jan-18 Mar-18 Sep-17
Jun-18 Dec-17
May-18 Mar-18
Sep-18
Retail
Sep-20 Jun-20
Sep-20
Services
Sep-20
FINANCIALS SECTOR UPDATE
Weighted average term-deposit rate SBI term-deposit rate vs. corporate-bond rate
Public Sector Banks Private Sector Banks SBI TD Rate (1-2 Yr) Corp Bond (AAA -1 Yr)
9.5 13.0
9.0 12.0
11.0
8.5
10.0
8.0
9.0
7.5
8.0
7.0
7.0
6.5
6.0
6.0 5.0
5.5 4.0
5.0 3.0
Jun-13
Dec-13
Jun-14
Dec-14
Jun-15
Dec-15
Jun-16
Dec-16
Jun-17
Dec-17
Jun-18
Dec-18
Jun-19
Dec-19
Jun-20
Sep-17
Sep-13
Sep-14
Sep-15
Sep-16
Sep-18
Sep-19
Sep-20
Mar-13
Mar-14
Mar-15
Mar-16
Mar-17
Mar-18
Mar-19
Mar-20
Sep-07
Sep-08
Sep-09
Sep-10
Sep-11
Sep-12
Sep-13
Sep-14
Sep-15
Sep-16
Sep-17
Sep-18
Sep-19
Sep-20
Source: RBI, PhillipCapital India Research
Median MCLR (%) Bank-wise MCLR change; bps (since Mar 2020)
South Indian
10.0 Public Private Bandhan
Indusind
Federal
Canara
Indian
Kotak
HDFC
BoM
UCO
ICICI
9.5
PNB
DCB
P&S
Axis
BoB
J&K
RBL
IOB
CBI
BoI
SBI
0
9.0
-20
8.5
-40
8.0
-60
7.5
-80
7.0
-100
Dec-16
Jun-17
Dec-17
Jun-18
Dec-18
Jun-19
Dec-19
Jun-20
Sep-16
Sep-17
Sep-18
Sep-19
Sep-20
Mar-17
Mar-18
Mar-19
Mar-20
-120
Bank valuation (P/Adj BV vs. RORWA-FY22) Bank valuation (P/Adj BV vs. RORWA-FY23)
4.5 Quartile 2 4.5
Quartile 3
4.0 4.0 Quartile 3 Quartile 2
Price to Adjusted Book Value
KMB 3.5
3.5 KMB
HDFC
3.0 3.0
2.5 HDFC
2.5
2.0 2.0
Axis ICICI ICICI Axis
1.5 Quartile 4
1.5 DCB IIB
IIB DCB
1.0 1.0
Quartile 1
0.5 0.5
Quartile 1 SBI
SBI Quartile 4 -
-
1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 2.6 2.8
1.0 1.2 1.4 1.6 1.8 2.0 2.2 2.4 2.6 2.8
Return on Risk Weighted Assets Return on Risk Weighted Assets
Source: Company, PhillipCapital India Research
100%
80%
60%
40%
20%
0%
2.0%
1.5%
1.0%
0.5%
0.0%
We tried to look at a few data points. While these may not be a complete
representation, they are still good indicators to assess underlying asset quality.
We believe that the corporate asset quality would remain resilient in the current
environment based on: (1) lower amount of corporate rating downgrades, and (2) a
bulk of the stressed book was already recognised in the corporate-NPA cycle of FY16-
18.
4,000
3,500
3,000
2,500
Rs bn
2,000
1,500
1,000
500
-
Jul-18
Dec-18
Jul-19
Jul-20
Jan-18
Mar-18
Apr-18
May-18
Oct-18
Apr-19
May-19
Oct-19
Dec-19
Jan-20
Oct-20
Mar-20
Apr-20
May-20
Feb-18
Nov-18
Jan-19
Mar-19
Jun-18
Aug-18
Sep-18
Feb-19
Jun-19
Aug-19
Sep-19
Nov-19
Feb-20
Jun-20
Aug-20
Sep-20
1,200
1,000
Rs bn
800
600
400
200
-
Jan-18
Mar-18
May-18
Jul-18
Jul-19
Jan-20
Apr-18
Oct-18
Mar-19
May-19
Apr-19
Oct-19
Mar-20
May-20
Jul-20
Oct-20
Feb-18
Jun-18
Dec-19
Apr-20
Aug-18
Sep-18
Nov-18
Dec-18
Jan-19
Feb-19
Jun-19
Aug-19
Sep-19
Nov-19
Feb-20
Jun-20
Aug-20
Sep-20
Source: Company, PhillipCapital India Research
Tracking the incremental flow of vulnerable pool within the overall rating downgrade,
it can be noticed that the exposure to the individual banks are insignificant. The flow
to top private banks is less than 0.5% whereas the flow to IndusInd and RBL are at
very manageable level.
Exposure as a % of Loan
1.60%
1.40%
1.20%
1.00%
0.80%
0.60%
0.40%
0.20%
0.00%
Federal ICICI DCB Kotak SBI Axis Bank IndusInd RBL
The bounce rate (in value terms) in auto-debit transactions has been at 32%,
higher than pre-covid levels of 25%.
The inverse of bounce rate, i.e., the success rate, is at 90% of pre-covid levels.
Collection efficiency rate was 95-98% of pre-covid rate.
The bounce rate numbers suggest that the collection efficiency has some
element of ‘one-time’; so, it may not be sustainable unless economic activity
improves further.
However, the CTS bounce-rate seems to have normalised to pre-covid levels of
c.7%.
The inference we can draw from the bounce rate data is that the collection efficiency
in retail loans may not be sustainable at the level reported in October 2020, but the
deviation is not large enough to be alarming.
35%
30%
25%
20%
15%
10%
5%
0%
Jun-14
Jun-15
Jun-16
Jun-17
Jun-18
Jun-19
Jun-20
Oct-13
Feb-14
Oct-14
Feb-15
Oct-15
Feb-16
Oct-16
Feb-17
Oct-17
Feb-18
Oct-18
Feb-19
Oct-19
Feb-20
Oct-20
12.0%
10.0%
8.0%
6.0%
4.0%
2.0%
0.0%
Oct-16
Oct-15
Jul-16
Jul-17
Oct-17
Jul-18
Oct-18
Jul-19
Oct-19
Jul-20
Oct-20
Apr-16
Apr-17
Apr-18
Apr-19
Apr-20
Jan-16
Jan-17
Jan-18
Jan-19
Jan-20
As per the TransUnion CIBIL report on the MSME CREDIT HEALTH INDEX (October
2020): “The impact of ECLGS on MSME lending is clearly visible. The number of loan
originations have accelerated in June 2020 due to deployment of funds under this
scheme. This is most likely to have a positive impact on the Growth Index in the near
future”.
2.6
2.5
2.0
1.5
Ease of liquidity
87% of all respondents said that the ECLGS facility had helped to ease their short-
term financial problems.
59% felt that the loan would sustain their business requirements only in the
short term (up to three months)
A much smaller proportion (19%) believed that it would ease liquidity problems
beyond three months.
The total stress book for top banks to range between 2.6%-7.3%.
However effective mortality rate is expected to be between 2.1%-4.2% for these
top banks.
Retail stressed loan pool is assessed based on collection efficiency (using peer
references).
The corporate stressed pool is based on exposure to vulnerable corporates.
The total stress is then classified into slippage and potential restructuring.
0 68 0 80
3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
0 80 0 70
3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
0 80 0 56
3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
DCB Bank
YOA % COD % NIM % CD ratio %, rhs
14 87
11.6 11.6 11.5 11.5 11.4 11.3
12 11.3 11.1 86
10
85
8 7.0 7.0 7.0 6.9
6.6 6.7 6.7 6.5 84
6
3.8 3.8 3.7 3.7 3.7 3.6 3.7 83
4 3.4
2 82
0 81
3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
These top lenders with low costs of fund and adequate capital are geared to garner
market share and provide formidable competition to banks and NBFCs that have
higher costs of funds. 2015-2020 saw banks like Axis Bank, ICICI Bank, IndusInd Bank,
HDFC Bank, Kotak Bank and SBI cumulatively gaining 9.3% market share in deposits.
This trend is likely to continue, as these entities are well prepared in terms of capital,
technological capability, and retail deposit franchises.
Sum-of-the-parts valuation
SOTP Valuation Stake Per share valuation Criteria
Parent 394 FY23 Adj book value
less: Investment in subsidiary 4 per share investment in subsidiary
core book value 390
Bank Valuation – A 683 1.75x FY23 core adj. book
Subsidiary
Axis AMC 75 57 8% FY23 average AUM of Rs 3 trillion, valuing entity at Rs 234bn
Axis Finance 100 12 2x FY23 adj networth of Rs18bn, valuing entity at Rs 37bn
Axis Capital 100 4 10x FY23 PAT of Rs1.3bn
Axis Securities 100 2 15x FY23 PAT of Rs 415mn
Total 68
1000 3x 84
6 5.4 5.4 5.3 5.2
5.0 5.0
800 4.7
4.4 83
2x
600 4 3.5 3.4 3.4 3.5 3.6 3.6 3.4 3.6
82
400 1x
2
81
200
0 0 80
Apr-17 Apr-18 Apr-19 Apr-20 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
0.00 88 0.0 0
FY20 FY21e FY22e FY23e FY20 FY21e FY22e FY23e
Financials
Most impacted MSME segment; will take longer time to recover: The extended lockdown NEUTRAL
due to the ongoing pandemic has hurt the MSME segment the most, not large corporates. CMP RS 112
The collection efficiency for loans against property (LAP)/Home loan/commercial vehicle TARGET RS 125 (+12%)
(CV) loans, as of September 2020 was 87.5%/91.3%/77.1%, lower than pre-covid levels of
97.5%/ 98.5%/92.1%. Around 93% of MFI (Micro Finance Institution) borrowers have paid at SEBI CATEGORY: SMALL CAP
least one EMI. DCBB has guided for restructuring of 3-5% and expects slippage to remain
elevated for the next 3-4 quarters. We factor 5% stressed portfolio (Refer to Table:5) within COMPANY DATA
which we model c.3% slippage; the rest 2.3% as standard restructured. A major contribution O/S SHARES (MN) : 310
MARKET CAP (RSBN) : 33.4
of stress can be seen from LAP and CV portfolios.
MARKET CAP (USDBN) : 0.5
52 - WK HI/LO (RS) : 205/ 58
Cautious approach to keep growth subdued in the near term: The focus of the bank is now LIQUIDITY 3M (USDMN) : 2.8
on collections and recovery, so that its portfolio quality is under control. Due to the lack of PAR VALUE (RS) : 2
adequate data pertaining to business activity for current or prospective customers, as a
cautious strategy, DCCB will not focus on growth in the near term. We have modelled credit SHARE HOLDING PATTERN, %
CAGR of 10% over FY20-23. Sep 20 Jun 20 Mar 20
Promoters : 14.9 14.9 14.9
FII / NRI / OCB : 37.7 35.9 35.3
Sustaining margins is a key challenge: Despite a 40bps decline in the cost of deposits in the FI / MF / Banks : 14.4 15.1 22.8
last nine months, DCBB’s yield on advances has declined by just 10bps. This can also be Indian Public : 33.0 34.1 27.0
because the loan book remained flat for the last few quarters. However, with re-pricing of
the existing loan book and incremental loan disbursement at a lower rate, NIM would see KEY FINANCIALS
pressure, even factoring some liquidity release in the balance sheet. Rs mn FY21e FY22e FY23e
Pre-prov ROE (%) 23.7 23.2 22.7
Pre-prov ROA (%) 2.3 2.3 2.3
Outlook and valuation
Net Profit 3,120 3,513 4,831
The MSME segment is hurt by extended lockdown and declining economic activity. % growth -7.7 12.6 37.5
DCBB’s MSME/LAP portfolio is backed by hard collateral, so the resultant loss-given EPS (Rs) 10.1 11.3 15.6
default may not be high. However, we are cautious about the delayed repayment and BVPS (Rs) 78.5 96.7 123.2
ROE (%) 8.7 8.8 10.9
resultant higher credit cost for the bank in the near term.
P/E (x) 11.1 9.9 7.2
We introduce FY23 financials and rollover our target multiple to FY23. We expect Adj P/BV (x) 1.4 1.2 0.9
earnings to move by -8%/+13%/+38% in FY21/22/23, translating into RoA of
0.85%/0.9%/1.1%.
Manish Agarwalla, Research Analyst
We maintain a Neutral rating with a revised target of Rs 125 (Rs 80 earlier) valuing the Sujal Kumar, Research Analyst
bank at 1x FY23 ABVPS of Rs 123. The stock trades at 1.4x/1.2x/0.9x FY21/22/23 ABVPS
of Rs 78/97/123.
0 0 81
Apr-17 Apr-18 Apr-19 Apr-20 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
Financials
Resilient asset quality: Its asset quality has shown resilience even during the economic COMPANY DATA
downturn. Various data points – such as collection efficiency, exposure to stressed O/S SHARES (MN) : 5507
MARKET CAP (RSBN) : 7894
corporates, or proportion of overdue accounts – do not indicate any meaningful increase in
MARKET CAP (USDBN) : 187.6
stress. We expect its total stressed pool to be around 3%, within which we factor c.2% to 52 - WK HI/LO (RS) : 1464 / 739
slip in FY21, and the rest getting restructured. LIQUIDITY 3M (USDMN) : 348
PAR VALUE (RS) : 2
NIM to remain stable: HDFCB has been able to maintain stable NIMs (4.1%-4.3%) across the
interest-rate cycle. Strong CASA base (42%) and retail deposits (63% of total deposits) should SHARE HOLDING PATTERN, %
Sep-20 Jun-20 Mar-20
help it to sustain its performance. Deployment of excess liquidity and improvement in CD
Promoters 21.2 21.2 21.2
ratio would enable the bank to maintain its NIMs at 4.1%-4.3%. The yield on advances has DII 18.6 18.0 17.9
grown 60bps, whereas cost of deposit declined by 50bps in the last nine months. FII 49.1 48.8 48.5
Public & Others 11.1 12.0 12.4
Improving customer experience and enhancing efficiencies: HDFC Bank has led the digital
transformation of the Indian financial services sector and continues to invest in technologies KEY FINANCIALS
to improve customer experience and enhance efficiencies. As a result, its cost-to-income Rs bn FY21e FY22e FY23e
ratio declined to 38.6% from 41% between FY18-20. We expect C/I ratio to decline further to Pre-prov ROE (%) 30.6 30.2 30.5
c.36.5% by FY23. Pre-prov ROA (%) 3.6 3.6 3.6
Net Profit 313 372 440
% growth 19.1 18.8 18.5
Outlook and valuation EPS (Rs) 57.0 67.8 80.3
A judicious mix of its retail and corporate loan book has enabled the bank to BVPS (Rs) 339.3 402.4 475.3
demonstrate strong loan-book growth despite a systemic slowdown. ROE (%) 16.9 17.2 17.4
Solid underwriting and strict monitoring of loans should enable it to contain its stressed P/E (x) 25.1 21.1 17.9
portfolio at manageable levels; we factor 2% slippage and 1% standard restructured Adj P/BV (x) 4.1 3.4 2.8
loans in FY21.
Manish Agarwalla, Research Analyst
Stable growth aided by tax cuts will help deliver PAT growth of c.19% in FY20-23. Sujal Kumar, Research Analyst
At CMP, its core book trades at 4.1x/3.4x/2.8x FY21/22/23 core-ABVPS of Rs
339/402/475, thus valuing the subsidiary at Rs 88 per share.
We introduce FY23 earnings and roll forward our target multiple to FY23. Maintain Buy
with a revised target of Rs 1,750 (up from Rs 1,380) at 3.5x FY23 ABVPS.
Sum-of-the-parts valuation
SOTP Valuation Stake Per share valuation Criteria
Parent 482 FY23 Adj book value
less: Investment in subsidiary 7 per share investment in subsidiary
core book value 475
Bank Valuation – A 1663 3.5x FY23 core adj. book
Subsidiary
HDB Financial 95.5 61 3.5x FY23 adj networth of Rs100bn, valuing entity at Rs 349bn
HDFC Securities 97.3 27 20x FY23 PAT of Rs7.6bn, valuing entity at Rs 152bn
Total 88
0 0 80
Apr-17 Apr-18 Apr-19 Apr-20 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
Financials
Well-poised to gain market share: ICICIBC’s strong capital base and superior retail SHARE HOLDING PATTERN, %
franchisee will help it to gain market share. Its recent capital raising (Rs 150bn) has Sep 20 Jun 20 Mar 20
FII / NRI / OCB : 36.1 37.8 36.4
improved its tier-1 ratio to 17.9% (the second-best after KMB’s 22.8%). Its greater share of
FI / MF / Banks : 55.6 53.4 54.5
low-cost deposits (CASA at 40%) and granular deposit composition (61% is retail deposits) Indian Public : 8.3 8.9 9.1
are elements for long-term business sustenance. The bank gained 1.6% market share
between 2015 and 2020, despite a weak corporate credit cycle between FY16 and FY18. KEY FINANCIALS
With this largely behind it, the bank is well poised to grab higher market share ahead. We Rs bn FY21 FY22E FY23E
model 11% CAGR for credit and deposit in FY20-23. Pre-prov ROE (%) 26.5 22.7 22.7
Pre-prov ROA (%) 3.2 3.0 3.0
Outlook and valuation Net Profit 143 180 208
We believe ICICIBC is best placed among peer banks based on its low exposure towards % growth 80.2 25.9 15.7
riskier segments (unsecured retail loans and MSMEs) in the current scenario. EPS (Rs) 20.7 26.0 30.0
BVPS (Rs) 179 201 222
Its collection efficiency returned to 97% of pre-covid levels + guidance of normalised ROE (%) 10.9 11.8 12.2
credit costs in FY22 provides confidence in its ability to manage in the current asset- P/E (x) 18.3 14.4 12.3
quality crisis, without a significant impact on its return ratios. Adj P/BV (x) 2.1 1.9 1.7
We have factored eventual mortality of c.3% and restructuring of c.2% in FY21.
Strong provision coverage (81.5%) along with covid-related buffer (Rs 88bn; 1.2% of Manish Agarwalla, Research Analyst
GCA) should enable it to meet post-moratorium credit shocks. Sujal Kumar, Research Analyst
We introduce FY23 financials and roll over our target multiple to FY23. We expect
earnings growth of 80%/+26%/+16% in FY21/22/23 translating into RoA of
1.3%/1.5%/1.6%.
At CMP, ICICIBC trades at 2.1x/1.9x/1.7x core ABVPS of Rs 179/201/222 (valuing
subsidiaries at Rs 117). We maintain buy with a revised TP of Rs 560 (Rs520 earlier).
Sum-of-the-parts valuation
Shareholding Valuation Valuation Criteria
of ICICI per share Rs
Value of Banking Business (1) 444 2x FY23E core ABVPS of Rs222
ICICI Securities ltd 77.2% 16 15x FY23E PAT of Rs9.8bn
ICICI Prudential life insurance company ltd 51.4% 50 20x FY23E NBAP of Rs21bn+EV of Rs257bn
ICICI Lombard General insurance company ltd 51.9% 51 35x FY23E PAT of Rs 19.4bn
ICICI AMC 51.0% 22 8% FY23E AUM of Rs4tln
Housing finance business 100.0% 2 1x FY22E ABV of Rs13bn
Overseas banking subsidiaries 5 0.5x current BV of Rs 68bn
Value of subsidiary 147
Less: Holding company discount @ 15% 29
Net value of Subsidiary (2) 117
Total (1) + (2) 561
Source: PhillipCapital India Research
0 0 68
Apr-17 Apr-18 Apr-19 Apr-20 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
Financials
Long road to normalised credit costs: The bank has a dominant presence in the segments NEUTRAL (Downgrade)
particularly hit hard by the post-pandemic lockdowns. Segments where the bank has a CMP RS 895
sizable presence – such as commercial real estate, commercial vehicles, micro finance, credit TARGET RS 925 (+3.4%)
cards, and MSMEs – have been relatively more affected. IIB’s overall stressed pool (Refer to
Table:5) of +7% translates into 3% slippage and 4% restructured book in FY21. The bank has SEBI CATEGORY: LARGE CAP
built in a provision buffer of Rs 21bn (1.1% of loan book). With the expected stress level,
credit costs should remain elevated for the next four quarters for the bank, before returning COMPANY DATA
to normalised levels. We have factored a credit cost of 3.5%/2.25% for FY21/22; IIB’s O/S SHARES (MN) : 756
MARKET CAP (RSBN) : 677
guidance is 3-4% for FY21.
MARKET CAP (USDBN) : 9
52 - WK HI/LO (RS) : 1596 / 236
Change in balance-sheet composition will moderate credit growth vs. past performance: LIQUIDITY 3M (USDMN) : 215.8
IIB’s strategy has shifted towards “retailisation of the balance sheet” with a focus on PAR VALUE (RS) : 2
improving its retail deposits franchise, increasing the contribution of non-vehicle retail loans
and the proportion of micro-finance business, and reducing exposure to low-rated corporate SHARE HOLDING PATTERN, %
groups. Because of the lack of credit demand in the system, finding adequate opportunity to Sep 20 Jun 20 Mar 20
Promoters : 13.5 13.3 13.0
meet the desired RAROC (risk adjusted return on capital) would be challenging. We have
FII / NRI / OCB : 15.2 13.4 14.1
modelled credit CAGR of 12% over FY20-23. FI / MF / Banks : 56.2 56.5 57.8
Indian Public : 15.2 16.9 15.1
Holding on to margins is a key challenge: Despite a 50bps decline in the costs of deposits in
the last nine months, IIB’s yield-on-advances has remained flat – which could be attributed KEY FINANCIALS
to loan book remaining flat for the last few quarters. However, with the re-pricing of its Rs bn FY21e FY22E FY23E
existing loan book and incremental loan disbursement at lower rates, its NIM should come Pre-prov ROE (%) 30.5 26.8 25.5
under pressure, even after factoring some release of liquidity in its balance sheet. Pre-prov ROA (%) 3.8 3.5 3.3
Net Profit 28 46 58
Outlook and valuation % growth -36.8 64.0 26.4
EPS (Rs) 36.9 59.3 74.9
IIB’s valuation has improved somewhat to 1.5x (one-year forward P/ABVPS) from a BVPS (Rs) 478.9 546.4 617.6
distressed level of 0.4x in March 2020. ROE (%) 7.4 10.5 11.8
However, the valuation is no longer at distressed levels. Developments in in the last six P/E (x) 24.3 15.1 12.0
months that allayed investors’ concerns were – restoration of depositors’ trust in the Adj P/BV (x) 1.9 1.6 1.4
bank, its ability to raise capital to protect its balance sheet, and finally, better-than-
expected recovery in business activity (collections, etc.).
The aftermath of the moratorium should start hitting banks in ensuing quarters. Manish Agarwalla, Research Analyst
Sujal Kumar, Research Analyst
IIB’s ability to return to its normal growth trajectory and credit cost would be a key
driver for its further re-rating. Here, we see challenges in terms of growth and see a
long wait before credit cost normalizes. We model credit CAGR of 12% in FY20-23, credit
cost of 3.5%/2.25% in FY21/22, and 3.3% slippage and 4% standard restructuring in
FY21.
We expect earnings growth of +37%/+64%/+26% in FY21/22/23 translating into RoA of
0.9%/1.4%/1.6%.
Based on return-on-risk-weighted-asset, some frontline private-sector banks (Axis, ICICI
Bank) are better placed – both in terms of valuation and return ratios – compared to IIB.
Hence, we downgrade the stock to NEUTRAL from BUY. At CMP, IIB trades at
1.9x/1.6x/1.4x ABVPS of Rs 479/546/618. Our revised target is Rs 925 (up from Rs 720
earlier), valuing the bank at 1.5x FY23E ABPVS of Rs 618.
0 0 80
Apr-17 Apr-18 Apr-19 Apr-20 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
Financials
0 0.0 70.0
Apr-17 Apr-18 Apr-19 Apr-20 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
Financials
Asset quality under control: A focus on top-rated borrowers and public-sector entities BUY
should help SBI to tide over the current economic cycle. A resilient retail loan portfolio and CMP RS 248
timely disbursement of ECLGS loans should contain the stress in its MSME portfolio. TARGET RS 310 (+25%)
Collection efficiency of 97.5% in October endows confidence in SBI’s overall asset quality.
We factor 3.5% stressed portfolio for the bank (Refer to Table:5) within which we have SEBI CATEGORY: LARGE CAP
modelled c.2.3% slippage and the balance 1.2% as standard restructured.
COMPANY DATA
Potential upside for margins: SBI quickly passed on falling costs of deposits to customers in O/S SHARES (MN) : 8925
MARKET CAP (RSBN) : 2180
the form of lower MCLR rates. The bank cut its deposit/lending rates by 60/50bps over the
MARKET CAP (USDBN) : 29.4
last nine months. It has been able to maintain its margin at 3.1%, despite a decline in its 52 - WK HI/LO (RS) : 345 / 149
credit-deposit ratio to 61% from 66-67% earlier. An improvement in the credit-deposit ratio LIQUIDITY 3M (USDMN) : 175.6
creates potential upside for its margin. PAR VALUE (RS) : 2
Weak operational matrices: SBI has lagged behind other large banks in terms of operational SHARE HOLDING PATTERN, %
efficiency matrices. SBI’s cost-to-income is way higher (at 56%) compared to HDFC Bank Sep 20 Jun 20 Mar 20
(40%) and ICICI Bank (45%). We do not foresee any near-term material changes in the Promoters : 56.9 56.9 56.9
FII / NRI / OCB : 25.2 24.6 24.4
matrix, given its weak topline growth.
FI / MF / Banks : 7.7 9.1 10.7
Indian Public : 10.3 9.4 8.0
Outlook and valuation: Strong collection efficiency numbers and encouraging management
commentary on asset quality were big positive surprises. We are sanguine about the asset KEY FINANCIALS
quality outcome because of the following reasons: (1) Its retail loans are largely to salaried Rs bn FY21e FY22e FY23e
and PSU entities. (2) The corporate-NPA cycle in FY16-18 already recognized a bulk of weak Pre-prov ROE (%) 31.9 32.4 30.2
and marginal cases in its corporate book. (3) The agriculture segment has done well in India Pre-prov ROA (%) 1.8 1.8 1.8
due to better rain and harvest. (4) Government’s ECLGS has aided the stressed MSME Net Profit 169 250 298
segment. % growth 16.7 48.1 19.0
Based on our analysis of credit exposure (refer to the table below), we factor a total EPS (Rs) 19.0 28.1 33.4
BVPS (Rs) 172.4 201.0 230.2
stressed book of 3.5% for FY21.
ROE (%) 7.9 10.7 11.6
We introduce FY23 financials and roll over our target multiple to FY23. P/E (x) 12.9 8.7 7.3
We expect earnings to move by -17%/+48%/+19% in FY21/22/23, translating into RoA of Adj P/BV (x) 0.7 0.6 0.5
0.4%/0.6%/0.7%.
At CMP, stock trades at 0.7x/0.6x/0.5x on FY21/22/23 core ABVPS of Rs 172/201/230
(subsidiary and investment value of Rs 126 per share). Manish Agarwalla, Research Analyst
Sujal Kumar, Research Analyst
Strong NII performance and manageable credit costs warrant a Buy rating, given its
subdued valuation. Maintain Buy with a revised TP of Rs 310 (up from Rs 285).
Sum-of-the-parts
Ownership Value/share Comment
Banking business (A) 184 0.8X FY23E Core -ABVPS OF Rs 230
SBI Life 55.5% 49 2.6x EV of Rs 298.6bn
SBI cards 69.5% 55 40 times FY22E PAT Rs 18bn
SBI Fund Mgt. 63.0% 20 30x of FY22E PAT of Rs 9.4bn
SBI General Insurance 70.0% 17 25 times FY22E PAT of Rs 8.8bn
SBI Caps 100.0% 5 15 times FY22E PAT of Rs 3bn
Subsidiary & associate value (B) 147
Yes Bank (C) 30.0% 10 Current market cap
Total (D) = (B+C) 157
Holding company discount @ 20% 31
Net value of subsidiary (D) 126
Fair Value (A) + (B) 310
6 66
1x 5.1 5.1 5.1 5.0 5.0 4.9
300 4.5 4.4 64
0.5x 4 3.1 62
200 2.8 2.8 2.8 2.9 3.1 3.0 3.0
60
100 2
58
0 0 56
Apr-17 Apr-18 Apr-19 Apr-20 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21
2.0 72 4
0.2
1.0 70 0.1 2
0.0 68 0.0 0
FY20 FY21e FY22e FY23e FY20 FY21e FY22e FY23e
Source: Company, PhillipCapital India Research
Financials
800
B (TP 850)850)
B (TP
700 B (TP 825)B (TP 800) B (TP 800)
B (TP 765)
600 B (TP 770) B (TP 700)
B (TP 560) B (TP 630)
500 B (TP 600)
N (TP 500)N (TP 490)
400
300
200
100
0
N-17 J-18 F-18 A-18 M-18 J-18 A-18 O-18 N-18 J-19 F-19 A-19M-19 J-19 A-19 O-19 N-19 J-20 F-20 A-20M-20 J-20 A-20 O-20 N-20
220
B (TP 250)
B (TP 240) N (TP 230)
180 B (TP 240) B (TP 205) S (TP 150) S (TP 150)
B (TP 215) B (TP 215)
140
100
N (TPN80)
(TP 80)
60 N (TP 67)
20
N-17 J-18 F-18 A-18 M-18 J-18 A-18 O-18 N-18 J-19 F-19 A-19 M-19 J-19 A-19 O-19 N-19 J-20 F-20 A-20 M-20 J-20 A-20 O-20 N-20
800
600
400
200
0
D-17 M-18 M-18 A-18 N-18 F-19 M-19 A-19 N-19 F-20 F-20 M-20 A-20 N-20
250
200
150
100
N-17 J-18 M-18 A-18 J-18 J-18 A-18 O-18 D-18 J-19 M-19 A-19 J-19 J-19 S-19 O-19 D-19 J-20 M-20 A-20 J-20 J-20 S-20 O-20
B (TP 2170)
2000 B (TP 2050)
B (TP 1900) B (TP 2170)
B (TP 2000) B (TP 1800)
B (TP 1800) B (TP 1640)
B (TP 1640)
1500
B (TP 1550)
1000
B (TP 720)
B (TP 740) B (TP 720)
500
0
D-17 J-18 M-18 A-18 M-18 J-18 A-18 O-18 N-18 J-19 F-19 A-19 M-19 J-19 A-19 O-19 N-19 J-20 F-20 M-20M-20 J-20 A-20 S-20 N-20
1800
N (TP 1660)
1600 N (TP 1485)
N (TP 1485)
1400 N (TP 1660) B (TP 1600)
B (TP 1450) B (TP 1450)
B (TP 1545)
1200 B (TP 1500)
BB(TP
(TP1545)
1500) B (TP 1450)
1000
800
J-18 F-18 A-18 M-18 J-18 A-18 S-18 N-18 D-18 F-19 M-19M-19 J-19 J-19 S-19 N-19 D-19 J-20 M-20 A-20 J-20 J-20 S-20 O-20 N-20
Stock Price, Price Target and Rating History (State Bank of India Bank)
400
150
100
50
0
N-17 J-18 B (TP A-18 M-18 J-18 A-18 O-18 N-18 J-19 F-19 A-19 M-19 J-19 A-19 S-19 N-19 D-19 F-20 M-20M-20 J-20 A-20 S-20 O-20
345)
Rating Methodology
We rate stock on absolute return basis. Our target price for the stocks has an investment horizon of one
year. We have different threshold for large market capitalisation stock and Mid/small market capitalisation
stock. The categorisation of stock based on market capitalisation is as per the SEBI requirement.
Certifications: The research analyst(s) who prepared this research report hereby certifies that the views expressed in this research report accurately reflect the
research analyst’s personal views about all of the subject issuers and/or securities, that the analyst(s) have no known conflict of interest and no part of the
research analyst’s compensation was, is, or will be, directly or indirectly, related to the specific views or recommendations contained in this research report.
Additional Disclosures of Interest:
Unless specifically mentioned in Point No. 9 below:
1. The Research Analyst(s), PCIL, or its associates or relatives of the Research Analyst does not have any financial interest in the company(ies) covered in
this report.
2. The Research Analyst, PCIL or its associates or relatives of the Research Analyst affiliates collectively do not hold more than 1% of the securities of the
company (ies)covered in this report as of the end of the month immediately preceding the distribution of the research report.
3. The Research Analyst, his/her associate, his/her relative, and PCIL, do not have any other material conflict of interest at the time of publication of this
research report.
4. The Research Analyst, PCIL, and its associates have not received compensation for investment banking or merchant banking or brokerage services or for
any other products or services from the company(ies) covered in this report, in the past twelve months.
5. The Research Analyst, PCIL or its associates have not managed or co-managed in the previous twelve months, a private or public offering of securities for
the company (ies) covered in this report.
6. PCIL or its associates have not received compensation or other benefits from the company(ies) covered in this report or from any third party, in
connection with the research report.
7. The Research Analyst has not served as an Officer, Director, or employee of the company (ies) covered in the Research report.
8. The Research Analyst and PCIL has not been engaged in market making activity for the company(ies) covered in the Research report.
9. Details of PCIL, Research Analyst and its associates pertaining to the companies covered in the Research report:
Independence: PhillipCapital (India) Pvt. Ltd. has not had an investment banking relationship with, and has not received any compensation for investment
banking services from, the subject issuers in the past twelve (12) months, and PhillipCapital (India) Pvt. Ltd does not anticipate receiving or intend to seek
compensation for investment banking services from the subject issuers in the next three (3) months. PhillipCapital (India) Pvt. Ltd is not a market maker in the
securities mentioned in this research report, although it, or its affiliates/employees, may have positions in, purchase or sell, or be materially interested in any
of the securities covered in the report.
Suitability and Risks: This research report is for informational purposes only and is not tailored to the specific investment objectives, financial situation or
particular requirements of any individual recipient hereof. Certain securities may give rise to substantial risks and may not be suitable for certain investors.
Each investor must make its own determination as to the appropriateness of any securities referred to in this research report based upon the legal, tax and
accounting considerations applicable to such investor and its own investment objectives or strategy, its financial situation and its investing experience. The
value of any security may be positively or adversely affected by changes in foreign exchange or interest rates, as well as by other financial, economic, or
political factors. Past performance is not necessarily indicative of future performance or results.
Sources, Completeness and Accuracy: The material herein is based upon information obtained from sources that PCIPL and the research analyst believe to be
reliable, but neither PCIPL nor the research analyst represents or guarantees that the information contained herein is accurate or complete and it should not
be relied upon as such. Opinions expressed herein are current opinions as of the date appearing on this material, and are subject to change without notice.
Furthermore, PCIPL is under no obligation to update or keep the information current. Without limiting any of the foregoing, in no event shall PCIL, any of its
affiliates/employees or any third party involved in, or related to computing or compiling the information have any liability for any damages of any kind
including but not limited to any direct or consequential loss or damage, however arising, from the use of this document.
Copyright: The copyright in this research report belongs exclusively to PCIPL. All rights are reserved. Any unauthorised use or disclosure is prohibited. No
reprinting or reproduction, in whole or in part, is permitted without the PCIPL’s prior consent, except that a recipient may reprint it for internal circulation only
and only if it is reprinted in its entirety.
Caution: Risk of loss in trading/investment can be substantial and even more than the amount / margin given by you. Investment in securities market are
subject to market risks, you are requested to read all the related documents carefully before investing. You should carefully consider whether
trading/investment is appropriate for you in light of your experience, objectives, financial resources and other relevant circumstances. PhillipCapital and any of
its employees, directors, associates, group entities, or affiliates shall not be liable for losses, if any, incurred by you. You are further cautioned that
trading/investments in financial markets are subject to market risks and are advised to seek independent third party trading/investment advice outside
PhillipCapital/group/associates/affiliates/directors/employees before and during your trading/investment. There is no guarantee/assurance as to returns or
profits or capital protection or appreciation. PhillipCapital and any of its employees, directors, associates, and/or employees, directors, associates of
PhillipCapital’s group entities or affiliates is not inducing you for trading/investing in the financial market(s). Trading/Investment decision is your sole
responsibility. You must also read the Risk Disclosure Document and Do’s and Don’ts before investing.
Kindly note that past performance is not necessarily a guide to future performance.
For Detailed Disclaimer: Please visit our website www.phillipcapital.in
for distribution to “major U.S. institutional investors” in reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act
of 1934, as amended (the “Exchange Act”). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this
report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not a
Major Institutional Investor.
Any U.S. recipient of this research report wishing to effect any transaction to buy or sell securities or related financial instruments based on the information
provided in this research report should do so only through Rosenblatt Securities Inc, 40 Wall Street 59th Floor, New York NY 10005, a registered broker dealer
in the United States. Under no circumstances should any recipient of this research report effect any transaction to buy or sell securities or related financial
instruments through PHILLIPCAP. Rosenblatt Securities Inc. accepts responsibility for the contents of this research report, subject to the terms set out below,
to the extent that it is delivered to a U.S. person other than a major U.S. institutional investor.
The analyst whose name appears in this research report is not registered or qualified as a research analyst with the Financial Industry Regulatory Authority
(“FINRA”) and may not be an associated person of Rosenblatt Securities Inc. and, therefore, may not be subject to applicable restrictions under FINRA Rules on
communications with a subject company, public appearances and trading securities held by a research analyst account.
Additional Disclosures
This research report is for distribution only under such circumstances as may be permitted by applicable law. This research report has no regard to the specific
investment objectives, financial situation or particular needs of any specific recipient, even if sent only to a single recipient. This research report is not
guaranteed to be a complete statement or summary of any securities, markets, reports or developments referred to in this research report. Neither
PHILLIPCAP nor any of its directors, officers, employees or agents shall have any liability, however arising, for any error, inaccuracy or incompleteness of fact or
opinion in this research report or lack of care in this research report’s preparation or publication, or any losses or damages which may arise from the use of
this research report.
PHILLIPCAP may rely on information barriers, such as “Chinese Walls” to control the flow of information within the areas, units, divisions, groups, or affiliates
of PHILLIPCAP.
Investing in any non-U.S. securities or related financial instruments (including ADRs) discussed in this research report may present certain risks. The securities
of non-U.S. issuers may not be registered with, or be subject to the regulations of, the U.S. Securities and Exchange Commission. Information on such non-U.S.
securities or related financial instruments may be limited. Foreign companies may not be subject to audit and reporting standards and regulatory
requirements comparable to those in effect within the United States.
The value of any investment or income from any securities or related financial instruments discussed in this research report denominated in a currency other
than U.S. dollars is subject to exchange rate fluctuations that may have a positive or adverse effect on the value of or income from such securities or related
financial instruments.
Past performance is not necessarily a guide to future performance and no representation or warranty, express or implied, is made by PHILLIPCAP with respect
to future performance. Income from investments may fluctuate. The price or value of the investments to which this research report relates, either directly or
indirectly, may fall or rise against the interest of investors. Any recommendation or opinion contained in this research report may become outdated as a
consequence of changes in the environment in which the issuer of the securities under analysis operates, in addition to changes in the estimates and forecasts,
assumptions and valuation methodology used herein.
No part of the content of this research report may be copied, forwarded or duplicated in any form or by any means without the prior written consent of
PHILLIPCAP and PHILLIPCAP accepts no liability whatsoever for the actions of third parties in this respect.
AGARWALLA
36f813cda9aabd351941b5394771851dd,
serialNumber=8f2fac440030280867a204de6
8440acc0f02155e901622e89b053ba0537514
a1, cn=MANISH AGARWALLA
Date: 2020.12.02 09:04:46 +05'30'